Risk of transmission of amyloid β pathology via transfused blood products
sbulaev
24 points
6 comments
August 23, 2026
Related Discussions
Found 5 related stories in 55.0ms across 4,152 title embeddings via pgvector HNSW
- Alzheimer's trial results lend momentum to strategies targeting tau lonelyasacloud · 24 pts · July 17, 2026 · 39% similar
- Semaglutide linked to lower predicted dementia risk randycupertino · 393 pts · August 15, 2026 · 39% similar
- Anthropic Risk August 2026 [pdf] artninja1988 · 54 pts · August 14, 2026 · 37% similar
- The AI risk is inside the labs mirzap · 41 pts · July 28, 2026 · 37% similar
- A controversial Alzheimer's surgery is said to reverse symptoms jeffreyrogers · 163 pts · August 15, 2026 · 37% similar
Discussion Highlights (1 comments)
echelon
We should be cloning monoclonal antigen free humans and harvesting blood from factories. All of medical science still imagines a world where humans are in "God's shape", denying the fact that we are machines made of systems of smaller machines. We could clone headless humans and have factories full of them. Transplants could cure all but brain cancer. Reverse aging too. Every time I meet a postdoc biologist and hear them drone on about the limits of detection, I'm furious we are overlooking the obvious answer to everything. The mechanization of the human body as a plant and lab. It's just going to take someone bold enough to do it, because people look at this as a horror. Like the first medical inquiry into cadavers being an affront to God. It would fix everything and propel the biological sciences hundreds of years into the future. We are dumb superstitious apes.